In patient with metastatic neuroendocrine tumours, Luthetium- 177 DOTATATE Therapy has been approved as the treatment of choice for symptomatic relief and extending survival.

Nuclear Medicine Dept. at Inlaks and Budhrani Hospital was one of the first few centres in India to standardise this therapy.

In castration resistant metastatic Prostate Cancer patients, this therapy is a ray of hope to patients when the other therapeutic options are exhausted. The Luthetium- 177 PSMA therapy not only gives symptom relief but also causes reduction in S.PSA levels.

A promising treatment for inflammatory arthritis without the known side effects of disease modifying drugs. It gives pain relief by reducing the inflammation in the synovial cavity of the joint .

Also, an effective remedy in hemophiliac joints.

Stimulation produced by withdrawal of thyroid hormones is required for the effective administration and treatment of a thyroid cancer patients with Iodine-131 large dose therapy.

However, some patients cannot tolerate hypothyroidism.

In such patients, Iodine-131 large dose therapy is administered under Inj .rh TSH stimulation.

In cancer patients with multiple painful skeletal metastasis, irradiation of the entire body for pain relief can have adverse effects.

Samarium-153 palliative pain therapy is an effective alternative to morphine related drugs.

A single injection provides pain relief up to 6 months duration.

In patients with Hepatocellular carcinoma, this therapy increases the progression free survival.